Kalexsyn, Inc

The world-class scientists of Dipharma, Inc. (formerly Kalexsyn) provide expertise in solving challenging synthetic problems from early API, API process impurities, custom synthesis, stable label, to medicinal chemistry. We offer clients an outstanding CRO experience with fixed quote and tailored short- and long-term FTE arrangements. In addition to our research laboratories in Kalamazoo, Michigan, we have a cGMP kilolab and accompanying QC facilities to supply Phase 1 and early Phase 2 needs, as well as a highly skilled process route development team

Medicinal chemistry,synthesis,process development,stable-label,and api impurity

Kalexsyn, inc operates in the Pharmaceutical manufacturing industry.

Kalexsyn, inc's revenue is 11m - 100m

Kalexsyn, inc has 11 - 50 employees.